Literature DB >> 18058266

Somatotropes maintain their immature cells through Insulin-like growth factor I (IGF-I).

Kotaro Yokoyama1, Chihiro Mogi, Kaoru Miura, Keisuke Kuroda, Kinji Inoue.   

Abstract

A pituitary tumor is considered to be composed of a heterogeneous population of hormone-producing endocrine cells, folliculo-stellate (FS) cells, and potential hormone-inactive progenitor cells to maintain a microenvironment such as that in angiogenesis for tumor development cooperatively. However, the system that maintains such a heterogeneous cell population has not been clarified yet. In the present study, we examined the mechanism for maintaining a heterogeneous cell population using two rat cell lines, MtT/S and MtT/E cells, which are known growth hormone (GH)-producing cells, and their progenitor cells, respectively. We found that conditioned medium of MtT/S cells could stimulate the growth of MtT/E cells. In addition, GH and insulin-like growth factor I (IGF-I) stimulated the growth of MtT/E cells. The messenger RNAs (mRNAs) of receptors for IGF-I and GH were expressed in the MtT/E cells. Moreover, IGF-I receptor inhibitor AG1024 could abolish the growth stimulatory activity in the conditioned medium of MtT/S cells. Therefore, we concluded that somatotropes (MtT/S) maintain their progenitor cells (MtT/E) through the GH-IGF-I signaling and IGF-I directly, which might be involved in the maintenance of progenitors of GH-producing cells and might contribute to pituitary tumor development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18058266     DOI: 10.1007/s12022-007-0016-6

Source DB:  PubMed          Journal:  Endocr Pathol        ISSN: 1046-3976            Impact factor:   4.056


  32 in total

1.  History and perspectives of pituitary folliculo-stellate cell research.

Authors:  Wilfried Allaerts; Hugo Vankelecom
Journal:  Eur J Endocrinol       Date:  2005-07       Impact factor: 6.664

2.  Different patterns of allelic loss (loss of heterozygosity) in recurrent human pituitary tumors provide evidence for multiclonal origins.

Authors:  R N Clayton; M Pfeifer; A B Atkinson; P Belchetz; J A Wass; E Kyrodimou; M Vanderpump; D Simpson; J Bicknell; W E Farrell
Journal:  Clin Cancer Res       Date:  2000-10       Impact factor: 12.531

3.  The adult pituitary contains a cell population displaying stem/progenitor cell and early embryonic characteristics.

Authors:  Jianghai Chen; Nicole Hersmus; Vik Van Duppen; Pieter Caesens; Carl Denef; Hugo Vankelecom
Journal:  Endocrinology       Date:  2005-06-02       Impact factor: 4.736

Review 4.  IGF-I receptor signalling: lessons from the somatotroph.

Authors:  S Melmed; S Yamashita; H Yamasaki; J Fagin; H Namba; H Yamamoto; M Weber; S Morita; J Webster; D Prager
Journal:  Recent Prog Horm Res       Date:  1996

5.  Effects of diethylstilbestrol on the cytogenesis of prolactin cells in the pars distalis of the pituitary gland of the mouse.

Authors:  M Matsubara; T Harigaya; H Nogami
Journal:  Cell Tissue Res       Date:  2001-11       Impact factor: 5.249

6.  Anatomy of the pituitary insulin-like growth factor system.

Authors:  M A Bach; C A Bondy
Journal:  Endocrinology       Date:  1992-12       Impact factor: 4.736

7.  Pituitary tumors in mice exposed prenatally to diethylstilbestrol.

Authors:  B E Walker; L A Kurth
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

8.  Stimulatory effect of insulin-like growth factor I on proliferation of mouse pituitary cells in serum-free culture.

Authors:  S Oomizu; S Takeuchi; S Takahashi
Journal:  J Endocrinol       Date:  1998-04       Impact factor: 4.286

9.  Molecular cloning of rat insulin-like growth factor I complementary deoxyribonucleic acids: differential messenger ribonucleic acid processing and regulation by growth hormone in extrahepatic tissues.

Authors:  C T Roberts; S R Lasky; W L Lowe; W T Seaman; D LeRoith
Journal:  Mol Endocrinol       Date:  1987-03

10.  Clonal origin of pituitary adenomas.

Authors:  V Herman; J Fagin; R Gonsky; K Kovacs; S Melmed
Journal:  J Clin Endocrinol Metab       Date:  1990-12       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.